Table 2.
Baseline characteristics according to the tertiles of SHR
| Total (n = 987) | T1(n = 329) | T2(n = 330) | T3(n = 328) | P-value | |
|---|---|---|---|---|---|
| Age (years) | 62 (54, 69) | 63 (55, 69) | 62(53, 69.25) | 63 (55, 69) | 0.465 |
| Male (n, %) | 706 (71.50%) | 250 (76%) | 242(73.30%) | 214 (65.20%) | 0.006 |
| NGR (n, %) | 262 (26.60%) | 79 (24%) | 112(33.9) | 71 (21.60%) | < 0.001 |
| Pre-DM (n, %) | 336 (34%) | 132 (40.10%) | 117 (35.50%) | 87 (26.50%) | |
| DM (n, %) | 389 (39.40%) | 118 (35.90%) | 101 (30.60%) | 170 (51.80%) | |
| Smoking (n, %) | 428 (43.40%) | 168 (51.10%) | 147 (44.50%) | 113 (34.50%) | < 0.001 |
| Drinking (n, %) | 134 (13.60%) | 48 (14.60%) | 46 (13.9%) | 40 (12.20%) | 0.651 |
| Hypertension (n, %) | 475 (48.10%) | 162 (49.20%) | 154 (46.70%) | 159 (48.50%) | 0.794 |
| BMI (kg/m2) | 25.39 (23.03, 28.01) | 25.09 (23.12, 27.78) | 25.75 (23.03, 28.41) | 25.39 (22.76, 27.55) | 0.544 |
| HbA1c (%) | 6 (5.60, 7) | 5.90 (5.60, 6.70) | 5.80 (5.50, 6.53) | 6.20 (5.70, 7.60) | < 0.001 |
| Glucose (mmol/l) | 7.33 (5.99, 9.85) | 5.74 (5.19, 6.49) | 7.05 (6.39, 8.34) | 10.22 (8.28, 13.82) | < 0.001 |
| TC (mmol/l) | 4.71 (3.95, 5.51) | 4.47 (3.81, 5.28) | 4.84 (4.07, 5.68) | 4.83 (4.01, 5.52) | 0.002 |
| TG (mmol/l) | 1.29 (0.91, 1.81) | 1.41 (1.04, 1.99) | 1.21 (0.88, 1.68) | 1.23 (0.86, 1.72) | < 0.001 |
| HDL-C(mmol/l) | 1.10 (0.92, 1.28) | 1 (0.86, 1.22) | 1.16(0.97, 1.30) | 1.13 (0.96, 1.29) | < 0.001 |
| LDL-C(mmol/l) | 3.07 (2.44, 3.73) | 2.87 (2.22, 3.52) | 3.20 (2.58, 3.90) | 3.21 (2.51, 3.72) | < 0.001 |
| UA (umol/l) | 376.05 (307.08, 459.03) | 371.40 (306.75, 462.60) | 384.05 (306.58, 463.85) | 371.80 (307.70, 448.10) | 0.694 |
| Cr (umol/l) | 80 (67, 97.25) | 79 (66.50, 97.50) | 81 (66, 97) | 82 (68, 99) | 0.446 |
| BNP (pg/ml) | 732 (227.50, 2240) | 633 (217, 1831.50) | 744 (242, 2007.25) | 904 (217, 2808) | 0.131 |
| D-dimer (ug/ml) | 106 (58, 224.25) | 105 (54.50, 202.50) | 109 (59.75, 217) | 101 (58, 241) | 0.945 |
| CRP (mg/l) | 6.46 (2.45, 13.48) | 6.79 (2.35, 13.28) | 6.49 (2.12, 13.61) | 6.30 (2.73, 13.70) | 0.951 |
| LAD (mm) | 35.80 (32.58, 38.70) | 35.60 (32.10, 38.60) | 35.85 (32.65, 38.80) | 36 (33, 38.70) | 0.415 |
| LVDd (mm) | 46.90 (43.90, 50.20) | 46.90 (43.80, 50.15) | 47 (44, 50.20) | 46.60 (44, 50.50) | 0.938 |
| LVDs (mm) | 30 (26.10, 34.50) | 29.70 (25.90, 34.75) | 30 (26.18, 34.75) | 30.20 (26.30, 34.90) | 0.868 |
| IVS (mm) | 10.80 (10.10, 11.70) | 10.80 (10.10, 11.60) | 10.80 (10.10, 11.70) | 10.80 (10.10, 11.80) | 0.984 |
| LVPW (mm) | 10.50 (10, 11.20) | 10.50 (10, 11.05) | 10.50(10, 11.20) | 10.50 (10, 11.20) | 0.945 |
| LVEF (%) | 58 (58.88, 62) | 58.50 (52, 62) | 58 (49, 61) | 57 (47, 62) | 0.069 |
| Multi-vessel CAD (n, %) | 717 (72.60%) | 210 (29.30%) | 249 (34.70%) | 258 (36%) | < 0.001 |
SHR stress hyperglycemia ratio, NGR normal glucose regulation, Pre-DM pre-diabetes mellitus, DM diabetes mellitus, BMI body mass index, HbA1c, glycated hemoglobin A1c, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, UA uric acid, Cr creatinine, BNP B-type natriuretic peptide, CRP C-reactive protein, LAD left atrial diameter, LVDd left ventricular end diastolic diameter, LVDs left ventricular systolic diameter, IVS interventricular septal thickness, LVPW left posterior wall thickness, LVEF left ventricular ejection fraction, CAD Coronary artery disease